Safety Profile and Neurocognitive Function Following Acute 4-Fluoroamphetamine (4-FA) Administration in Humans

Eliza B. de Sousa Fernandes Perna, Eef L. Theunissen, Patrick C. Dolder, Natasha L. Mason, Nadia R. P. W. Hutten, Stefan W. Toennes, Kim P. C. Kuypers, Johannes G. Ramaekers*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Article number713
Number of pages11
JournalFrontiers in Pharmacology
Volume9
DOIs
Publication statusPublished - 6 Jul 2018

Keywords

  • 4-FA
  • phase-1
  • safety
  • neurocognition
  • novel psychoactive substance
  • PSYCHOACTIVE SUBSTANCES NPS
  • MDMA 75 MG
  • D-AMPHETAMINE
  • MEPHEDRONE TOXICITY
  • HEALTHY-VOLUNTEERS
  • MEMORY IMPAIRMENT
  • ACUTE TOLERANCE
  • MOOD
  • METHAMPHETAMINE
  • METHYLPHENIDATE

Cite this